Gene Salkind - 11 Feb 2026 Form 4 Insider Report for Coeptis Therapeutics Holdings, Inc. (COEP)

Role
Director
Signature
/s/ Gene Salkind
Issuer symbol
COEP
Transactions as of
11 Feb 2026
Net transactions value
+$60,192
Form type
4
Filing time
13 Feb 2026, 17:00:05 UTC
Previous filing
02 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Salkind Gene Director 105 BRADFORD ROAD, SUITE 420, WEXFORD /s/ Gene Salkind 13 Feb 2026 0001592481

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COEP Common stock Options Exercise $60,192 +5,700 +76% $10.56 13,161 11 Feb 2026 Direct F1, F3
transaction COEP Common Stock Award $0 +3,250 +33% $0.000000 13,161 11 Feb 2026 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the exercise price of shares purchased upon exercise of stock options.
F2 Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock.
F3 Includes 4,211 shares of common stock that are held as JTWROS with Catherine Salkind.